Rachel Margolis-Goodman: When Conventional Treatment Could Not, Research Found an Answer
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared Versiti Inc.’s post on LinkedIn:
“Semi is alive today because research found an answer when conventional treatment could not.
After his bone marrow transplant, Semi’s body rejected every platelet transfusion. Researchers at the Versiti Blood Research Institute identified an exceptionally rare condition and the specialized platelet match that helped save his life.
This is the power of blood research.
If you believe every patient deserves access to lifesaving discoveries, I invite you to read Semi’s story and support the work of VBRI.”
Versiti Inc. shared a post on LinkedIn:
“A bone marrow transplant gave Semi a second chance. Research made sure he could receive it.
When 16-year-old Semi’s body rejected every platelet transfusion after his transplant, his care team turned to the Versiti Blood Research Institute for answers.
Researchers uncovered an exceptionally rare condition and identified the specialized platelet match that helped save his life.
It’s a powerful example of what becomes possible when researchers, laboratory experts, physicians and blood donors work together.
Read Semi and Temi’s inspiring story.
We’re grateful to Zizzo Group – Engagement Marketing for their partnership in bringing Semi and Temi’s story to life.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 17:27Carly Newton: Closing the Gap in Sickle Cell Disease Readmissions
-
Sep 15, 2026, 17:26Jared Rice: Understanding Extreme Platelet Counts in Preterm Infants
-
Sep 15, 2026, 17:25Gregg W. Stone: OCT-Guided PCI Reduces Stent Thrombosis in Patients With Diabetes
-
Sep 15, 2026, 15:29Abdul Muqtadir Abbasi: Recognizing Thalassemia Trait Is Essential for Every Physician
-
Sep 15, 2026, 15:17Shehab Mohamed: A New Regional Consensus on HLH Diagnosis and Management
-
Sep 15, 2026, 15:17Sheharyar Raza: Managing Randomness in Artificial Intelligence for Transfusion Medicine
-
Sep 15, 2026, 15:00Sarah Wachtman: Modeling AAV-Based Gene Therapy for Hemophilia A Using Pediatric Liver Organoids
-
Sep 15, 2026, 15:00Ashenafi Tazebew Amare: From Blood Donation to Innovation and Patient Access
-
Sep 15, 2026, 14:56Glanzmann Thrombasthenia Beyond Platelet Transfusion